Has iLivTouch been approved in any key market?
A：
We have obtained the registration certificate issued by State FDA in May, 2012. Our iLivTouch is the first image-guided non-invasive liver fibrosis diagnostic system with transient elastography around the world.
Other FAQ
What are primary uses of iLivTouch?
How do you develop your quantitative standard of fatty liver? Has it been approved?
Does the level of liver fibrosis affect the measurement of fatty liver?
What is the size of liver that iLivTouch measure for liver stiffness?
What is the dynamic broadband technology used in iLivTouch?